Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
1
Issued Date
2022-03-02
Resource Type
eISSN
25160230
Scopus ID
2-s2.0-85128156627
Journal Title
Nanoscale Advances
Volume
4
Issue
8
Start Page
1988
End Page
1998
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nanoscale Advances Vol.4 No.8 (2022) , 1988-1998
Suggested Citation
Mekseriwattana W., Guardia P., Herrero B.T., de la Fuente J.M., Kuhakarn C., Roig A., Katewongsa K.P. Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells. Nanoscale Advances Vol.4 No.8 (2022) , 1988-1998. 1998. doi:10.1039/d2na00015f Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/84101
Title
Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
Other Contributor(s)
Abstract
Breast cancer accounts for up to 10% of the newly diagnosed cancer cases worldwide, making it the most common cancer found in women. The use of superparamagnetic iron oxide nanoparticles (SPIONs) has been beneficial in the advancement of contrast agents and magnetic hyperthermia (MH) for the diagnosis and treatment of cancers. To achieve delivery of SPIONs to cancer cells, surface functionalization with specific ligands are required. Riboflavin carrier protein (RCP) has been identified as an alternative target for breast cancer cells. Here, we report a novel riboflavin (Rf)-based ligand that provides SPIONs with enhanced colloidal stability and high uptake potential in breast cancer cells. This is achieved by synthesizing an Rf-citrate ligand. The ligand was tested in a multicore SPION system, and affinity to RCP was assessed by isothermal titration calorimetry which showed a specific, entropy-driven binding. MRI and MH responses of the coated Rf-SPIONs were tested to evaluate the suitability of this system as a theranostic platform. Finally, interaction of the Rf-SPIONs with breast cancer cells was evaluated by in vitro cellular uptake in MCF-7 breast cancer cells. The overall characterization of the Rf-SPIONs highlighted the excellent performance of this platform for theranostic applications in breast cancer.